{"id":"https://openalex.org/W2167780425","doi":"https://doi.org/10.1517/14712598.2012.704015","title":"Bevacizumab treatment of prostate cancer","display_name":"Bevacizumab treatment of prostate cancer","publication_year":2012,"publication_date":"2012-07-09","ids":{"openalex":"https://openalex.org/W2167780425","doi":"https://doi.org/10.1517/14712598.2012.704015","mag":"2167780425","pmid":"https://pubmed.ncbi.nlm.nih.gov/22775507"},"language":"en","primary_location":{"id":"doi:10.1517/14712598.2012.704015","doi":"https://doi.org/10.1517/14712598.2012.704015","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14712598.2012.704015","pdf_url":null,"source":{"id":"https://openalex.org/S57380513","display_name":"Expert Opinion on Biological Therapy","issn_l":"1471-2598","issn":["1471-2598","1744-7682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Biological Therapy","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027316759","display_name":"Alexander Small","orcid":"https://orcid.org/0000-0002-1584-4690","observed_orcids":["https://orcid.org/0000-0002-1584-4690"]},"institutions":[{"id":"https://openalex.org/I1324220072","display_name":"Mount Sinai Hospital","ror":"https://ror.org/01zkyz108","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1320796813","https://openalex.org/I1324220072"]},{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander C Small","raw_affiliation_strings":["Mount Sinai School of Medicine, Division of Hematology and Medical Oncology , 1 Gustave L Levy Place, Box 1128, New York, NY 10029, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mount Sinai School of Medicine, Division of Hematology and Medical Oncology , 1 Gustave L Levy Place, Box 1128, New York, NY 10029, USA","institution_ids":["https://openalex.org/I1324220072","https://openalex.org/I98704320"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078027978","display_name":"William K. Oh","orcid":"https://orcid.org/0000-0001-5113-8147","observed_orcids":["https://orcid.org/0000-0001-5113-8147"]},"institutions":[{"id":"https://openalex.org/I1324220072","display_name":"Mount Sinai Hospital","ror":"https://ror.org/01zkyz108","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1320796813","https://openalex.org/I1324220072"]},{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William K Oh","raw_affiliation_strings":["Mount Sinai School of Medicine, Division of Hematology and Medical Oncology, 1 Gustave L Levy Place, Box 1128, New York, 10029, USA william.oh@mssm.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mount Sinai School of Medicine, Division of Hematology and Medical Oncology, 1 Gustave L Levy Place, Box 1128, New York, 10029, USA william.oh@mssm.edu","institution_ids":["https://openalex.org/I1324220072","https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2361,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.20537682,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"12","issue":"9","first_page":"1241","last_page":"1249"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.926800012588501,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.926800012588501,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.06849999725818634,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":1.0},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.9490000009536743},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.996999979019165},{"id":"https://openalex.org/keywords/anti-vegf-monoclonal-antibody","display_name":"anti-VEGF monoclonal antibody","score":0.9639999866485596},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9309999942779541},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.859000027179718},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.675000011920929},{"id":"https://openalex.org/keywords/metastatic-prostate-cancer","display_name":"metastatic prostate cancer","score":0.9319999814033508},{"id":"https://openalex.org/keywords/localized-prostate-cancer","display_name":"localized prostate cancer","score":0.8199999928474426},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.7770000100135803}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8247896432876587},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7538467645645142},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6467931866645813},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.4867584705352783},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44817084074020386},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40732628107070923},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.402736634016037},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.19937679171562195}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1517/14712598.2012.704015","doi":"https://doi.org/10.1517/14712598.2012.704015","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14712598.2012.704015","pdf_url":null,"source":{"id":"https://openalex.org/S57380513","display_name":"Expert Opinion on Biological Therapy","issn_l":"1471-2598","issn":["1471-2598","1744-7682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Biological Therapy","raw_type":"journal-article"},{"id":"pmid:22775507","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22775507","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on biological therapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W178904883","https://openalex.org/W961447483","https://openalex.org/W1497429764","https://openalex.org/W1504644323","https://openalex.org/W1542216227","https://openalex.org/W1879747226","https://openalex.org/W1968710139","https://openalex.org/W1972539651","https://openalex.org/W1974425256","https://openalex.org/W1978139448","https://openalex.org/W1979591854","https://openalex.org/W1985712533","https://openalex.org/W1988511213","https://openalex.org/W1991355732","https://openalex.org/W1995168398","https://openalex.org/W2011011592","https://openalex.org/W2014604539","https://openalex.org/W2023288243","https://openalex.org/W2034753907","https://openalex.org/W2036245537","https://openalex.org/W2046599355","https://openalex.org/W2053726955","https://openalex.org/W2054728198","https://openalex.org/W2054822632","https://openalex.org/W2070428637","https://openalex.org/W2075864291","https://openalex.org/W2088776782","https://openalex.org/W2093656146","https://openalex.org/W2096123576","https://openalex.org/W2096134439","https://openalex.org/W2099328146","https://openalex.org/W2100128029","https://openalex.org/W2100669312","https://openalex.org/W2100945326","https://openalex.org/W2101918466","https://openalex.org/W2103563357","https://openalex.org/W2104938382","https://openalex.org/W2111199038","https://openalex.org/W2120292596","https://openalex.org/W2121785313","https://openalex.org/W2125447919","https://openalex.org/W2126275851","https://openalex.org/W2127745545","https://openalex.org/W2127988517","https://openalex.org/W2129331774","https://openalex.org/W2130334661","https://openalex.org/W2145224595","https://openalex.org/W2145835533","https://openalex.org/W2147692998","https://openalex.org/W2150909545","https://openalex.org/W2154200023","https://openalex.org/W2157769714","https://openalex.org/W2164782357","https://openalex.org/W2165088640","https://openalex.org/W2167224460","https://openalex.org/W2275872217","https://openalex.org/W2584952455","https://openalex.org/W2589132608","https://openalex.org/W2999214998"],"related_works":["https://openalex.org/W2803600261","https://openalex.org/W132676392","https://openalex.org/W2016548090","https://openalex.org/W2023103815","https://openalex.org/W2744681724","https://openalex.org/W1987019997","https://openalex.org/W2049353809","https://openalex.org/W2947913598","https://openalex.org/W1984696385","https://openalex.org/W2083479959"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Angiogenesis":[1],"plays":[2],"an":[3],"important":[4],"role":[5,137],"in":[6,45,65,74,80,89,98,109,128,140],"the":[7,57,113,119,135,141],"development":[8],"and":[9,26,95,100],"progression":[10],"of":[11,23,48,59,138,143],"prostate":[12,66,110,122,144],"cancer.":[13,67,111,145],"Vascular":[14],"endothelial":[15],"growth":[16],"factor":[17],"(VEGF)":[18],"is":[19,27,34],"a":[20,28,35,46],"primary":[21],"mediator":[22],"this":[24,53],"process":[25],"target":[29],"for":[30,63],"novel":[31,92],"therapies.":[32],"Bevacizumab":[33,105],"recombinant":[36],"anti-VEGF":[37],"monoclonal":[38],"antibody":[39],"that":[40,121],"has":[41,106],"demonstrated":[42],"antitumor":[43],"activity":[44,108],"variety":[47],"cancers.":[49],"AREAS":[50],"COVERED:":[51],"In":[52],"review,":[54],"we":[55],"present":[56],"results":[58,117],"several":[60],"clinical":[61,84,115],"trials":[62,70,85],"bevacizumab":[64,88,139],"Overall,":[68],"these":[69],"have":[71],"shown":[72],"improvements":[73],"progression-free":[75],"survival":[76],"but":[77],"no":[78],"changes":[79],"overall":[81],"survival.":[82],"Ongoing":[83],"are":[86],"testing":[87],"combination":[90],"with":[91],"cytotoxic":[93],"drugs":[94],"targeted":[96],"therapies":[97],"metastatic":[99],"localized":[101],"settings.":[102],"EXPERT":[103],"OPINION:":[104],"biological":[107],"However,":[112],"mixed":[114],"trial":[116],"support":[118],"theory":[120],"cancers":[123],"may":[124],"be":[125],"driven":[126],"only":[127],"part":[129],"by":[130],"angiogenesis.":[131],"Questions":[132],"remain":[133],"about":[134],"future":[136],"treatment":[142]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}